Indefinite Delivery Contract SPE2DU25D1027

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2DR25D2105 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines,...
The Indefinite Delivery Contract (IDC) SPE2DR25D7062 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,999,999,999 IDC, running through December 2036, is a prime vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The underlying solicitation, known as the...
The Indefinite Delivery Contract (IDC) SPE2DR25D2001 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The IDC has a ceiling value of $999,999,999 and a period of performance through December 31, 2036. It serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
The Indefinite Delivery Contract (IDC) SPE2DU25D5117 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $999,999,999 and runs through December 2036, serving as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes...
The Indefinite Delivery Contract (IDC) SPE2DU25D5133 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,999,999, has an ultimate completion date of December 31, 2036 and covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC is part of the...
The Indefinite Delivery Contract (IDC) SPE2DU25D5201 was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The single-award IDC has a ceiling value of $4,999,999 and runs through December 31, 2036. It is part of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish prime vendor contracts to provide worldwide pharmaceutical support to various DoD customers, including the...
The Indefinite Delivery Contract (IDC) SPE2DU25D5136 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999.00 single-award IDC has an ultimate completion date of December 31, 2036 and provides a mechanism for the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
The Indefinite Delivery Contract (IDC) SPE2DR25D1116 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC has an ultimate completion date of December 31, 2036 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The original...
The Indefinite Delivery Contract (IDC) SPE2DR25D3941, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, is a $999,999,999 contract to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
The Indefinite Delivery Contract (IDC) SPE2DR25D3301 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines,...

The Indefinite Delivery Contract (IDC) SPE2DU25D1027, awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $4,999,999 IDC has a period of performance through December 31, 2036 and serves as a primary vehicle for the DLA to procure specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas.

This IDC was established under the planned Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) solicitation, which intends to award multiple regional primary supplier contracts valued at an estimated $30.3 billion to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The solicitation is an unrestricted, fully competitive acquisition using a Lowest Price Technically Acceptable (LPTA) evaluation approach, with the option to leverage reverse auctions to obtain the best distribution fees for the primary suppliers.

Generated 6/6/25, 10:08 AM